Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Balloon + Oxytocin Versus Oral Misoprostol to Induce Labor in Case of Premature Rupture of Membranes (PROM) at Term in Nulliparous: a Randomized Controlled Trial (RUBAPRO2).

NCT05568745 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT05568745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05568745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Balloon + Oxytocin Versus Oral Misoprostol to Induce Labor in Case of Premature Rupture of Membranes (PROM) at Term in Nulliparous: a Randomized Controlled Trial (RUBAPRO2).
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Phase 4
Overall status
Unknown status
Start date
January 18, 2023
Completion date
February 28, 2026
Enrollment
520 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cervical ripening, induction of labor, nulliparous, premature rupture of fetal membranes